MATTHEW POTTER: Open Payments
NPI 1578004305 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 9 payments from 7 companies in 2025. Trend: 2023 $608 · 2024 $590 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $47 |
| UCB, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Braeburn Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: MOUNJARO, Rystiggo, VYEPTI, GLASSIA, TRELEGY ELLIPTA, BRIXADI, MAVYRET.
Industry payments across KY — which companies pay providers there.
